These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9366972)

  • 1. Treatment of early AIDS dementia in intravenous drug users: high versus low dose peptide T.
    Kosten TR; Rosen MI; McMahon TL; Bridge TP; O'Malley SS; Pearsall R; O'Connor PG
    Am J Drug Alcohol Abuse; 1997 Nov; 23(4):543-53. PubMed ID: 9366972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.
    Heseltine PN; Goodkin K; Atkinson JH; Vitiello B; Rochon J; Heaton RK; Eaton EM; Wilkie FL; Sobel E; Brown SJ; Feaster D; Schneider L; Goldschmidts WL; Stover ES
    Arch Neurol; 1998 Jan; 55(1):41-51. PubMed ID: 9443710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide T.
    GMHC Treat Issues; 1995 Dec; 9(12):8. PubMed ID: 11363001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group.
    Sidtis JJ; Gatsonis C; Price RW; Singer EJ; Collier AC; Richman DD; Hirsch MS; Schaerf FW; Fischl MA; Kieburtz K
    Ann Neurol; 1993 Apr; 33(4):343-9. PubMed ID: 8489204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological effects of AIDS studied.
    J Psychosoc Nurs Ment Health Serv; 1991 Jun; 29(6):31. PubMed ID: 1920192
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.
    Goodkin K; Vitiello B; Lyman WD; Asthana D; Atkinson JH; Heseltine PN; Molina R; Zheng W; Khamis I; Wilkie FL; Shapshak P
    J Neurovirol; 2006 Jun; 12(3):178-89. PubMed ID: 16877299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide T not effective for cognitive impairment.
    Posit Aware; 1996; 7(1):5. PubMed ID: 11363121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological and neurological manifestations of HIV-1 dementia in drug users.
    Handelsman L; Aronson M; Maurer G; Wiener J; Jacobson J; Bernstein D; Ness R; Herman S; Losonczy M; Song IS
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):21-8. PubMed ID: 1627958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of extended peptide T administration in AIDS and ARC patients.
    Bridge TP; Heseltine PN; Parker ES; Eaton EM; Ingraham LJ; McGrail ML; Goodwin FK
    Psychopharmacol Bull; 1991; 27(3):237-45. PubMed ID: 1775594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide T for cognitive impairment.
    Smart T
    GMHC Treat Issues; 1995 Sep; 9(9):15. PubMed ID: 11362907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal neuropsychological evaluation of HIV-infected intravenous drug users.
    Bono G; Mauri M; Sinforiani E; Barbarini G; Minoli L; Fea M
    Addiction; 1996 Feb; 91(2):263-8. PubMed ID: 8835281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide T and glucose metabolism in AIDS dementia complex.
    Villemagne VL; Phillips RL; Liu X; Gilson SF; Dannals RF; Wong DF; Harris PJ; Ruff M; Pert C; Bridge P; London ED
    J Nucl Med; 1996 Jul; 37(7):1177-80. PubMed ID: 8965193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort.
    Day JJ; Grant I; Atkinson JH; Brysk LT; McCutchan JA; Hesselink JR; Heaton RK; Weinrich JD; Spector SA; Richman DD
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):15-20. PubMed ID: 1627957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study.
    Starace F; Baldassarre C; Biancolilli V; Fea M; Serpelloni G; Bartoli L; Maj M
    Acta Psychiatr Scand; 1998 Feb; 97(2):132-8. PubMed ID: 9517907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remarkable improvement of neuropsychiatric symptoms in HIV-infected patients after AZT therapy.
    Hollweg M; Riedel RR; Goebel FD; Schick U; Naber D
    Klin Wochenschr; 1991 Jun; 69(9):409-12. PubMed ID: 1921244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group.
    Simpson DM; Dorfman D; Olney RK; McKinley G; Dobkin J; So Y; Berger J; Ferdon MB; Friedman B
    Neurology; 1996 Nov; 47(5):1254-9. PubMed ID: 8909439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients.
    Silberstein CH; O'Dowd MA; Chartock P; Schoenbaum EE; Friedland G; Hartel D; McKegney FP
    Gen Hosp Psychiatry; 1993 Nov; 15(6):351-9. PubMed ID: 8112557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone in drug users with AIDS or AIDS-related complex.
    Batki SL
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):111S-115S. PubMed ID: 2376626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
    Daveson AJM; Ee HC; Andrews JM; King T; Goldstein KE; Dzuris JL; MacDougall JA; Williams LJ; Treohan A; Cooreman MP; Anderson RP
    EBioMedicine; 2017 Dec; 26():78-90. PubMed ID: 29191561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.